Gene expression and promoter polymorphisms of DNA methyltransferase 3 B in nasopharyngeal carcinomas in Taiwanese people : A case-control study

Overexpression of the DNA methyltransferase 3B (DNMT3B) gene and its effect on carcinogenesis has been demonstrated for various types of cancer. Recently, three single nucleotide polymorphisms (SNPs) of the DNMT3B promoter region, C46359T (-149C>T), -283T>C, and -579G>T have also been reported to be stratification markers that can predict an individual's susceptibility to cancers. In this study, we analyzed expression of DNMT3B in nasopharyngeal carcinoma (NPC) specimens and did not find elevated levels of DNMT3B in tumors using cDNA microarray analysis and RT-PCR. Meanwhile, 259 NPC patients and 250 controls were genotyped for the above three SNPs using a MALDI-TOF based minisequencing method. For C46359T (-149C>T), only the T/T genotype was found to be present in both patient and control groups (100% frequency). The frequency of the genotypes, -283CC, -283CT and -283TT, amongst NPC patients versus controls was, respectively, 86.1% versus 84.0%, 13.5% versus 15.6%, and 0.4% versus 0.4% (P=0.589). The allele frequency, -597TT, -597GT and -597GG, for patients versus controls was, respectively, 87.3% versus 84.8%, 12.0% versus 15.2%, and 0.8% versus 0 (P=0.501). The distribution of SNPs among cancer patients either featuring or not featuring cervical metastasis also did not reveal any significant difference. In conclusion, our data indicate that neither overexpression of DNMT3B nor the presence of three DNMT3B SNPs are associated with NPC, which suggests that DNMT3B might not play a role in hypermethylation of many tumor suppressor genes during carcinogenesis of NPC.

[1]  Kai-Ping Chang,et al.  Promoter polymorphisms of DNMT3B and the risk of head and neck squamous cell carcinoma in Taiwan: a case-control study. , 2007, Oral oncology.

[2]  H. Hsu,et al.  Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer. , 2007, Lung cancer.

[3]  Ying Liang,et al.  Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. , 2006, Cancer research.

[4]  B. Goh,et al.  Analyses of promoter hypermethylation for RUNX3 and other tumor suppressor genes in nasopharyngeal carcinoma. , 2006, Anticancer research.

[5]  S. Jang,et al.  A novel DNMT3B subfamily, DeltaDNMT3B, is the predominant form of DNMT3B in non-small cell lung cancer. , 2006, International journal of oncology.

[6]  Kazuhiro Yoshida,et al.  No evidence of correlation between the single nucleotide polymorphism of DNMT3B promoter and gastric cancer risk in a Japanese population. , 2005, Oncology reports.

[7]  Yue Dai,et al.  [The C46359T polymorphism of DNMT3B promoter gene and pathogenesis of acute leukemia]. , 2005, Zhonghua nei ke za zhi.

[8]  K. Robertson DNA methylation and human disease , 2005, Nature Reviews Genetics.

[9]  J. Schlesselman,et al.  Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. , 2005, Oncology reports.

[10]  W. Guo,et al.  Single nucleotide polymorphism in DNA methyltransferase 3B promoter and its association with gastric cardiac adenocarcinoma in North China. , 2005, World journal of gastroenterology.

[11]  J. Sham,et al.  Nasopharyngeal carcinoma , 2005, The Lancet.

[12]  Yidi Su,et al.  Parallel minisequencing followed by multiplex matrix-assisted laser desorption/ionization mass spectrometry assay for β-thalassemia mutations , 2005, Journal of Human Genetics.

[13]  N. Eberhardt,et al.  Up-regulation of DNA methyltransferase 3B expression in endometrial cancers. , 2005, Gynecologic oncology.

[14]  Y. Yuasa,et al.  Transcriptional regulation of the human DNA methyltransferase 3A and 3B genes by Sp3 and Sp1 zinc finger proteins. , 2005, The Biochemical journal.

[15]  I. Bièche,et al.  Identification of a three-gene expression signature of poor-prognosis breast carcinoma , 2004, Molecular Cancer.

[16]  J. Park,et al.  DNMT3B polymorphisms and risk of primary lung cancer. , 2004, Carcinogenesis.

[17]  D. Eccles,et al.  The DNMT3B C→T promoter polymorphism and risk of breast cancer in a British population: a case-control study , 2004, Breast Cancer Research.

[18]  Peter A. Jones,et al.  Role of the DNA methyltransferase variant DNMT3b3 in DNA methylation. , 2004, Molecular cancer research : MCR.

[19]  Sebastian Böcker,et al.  High-throughput MALDI-TOF discovery of genomic sequence polymorphisms. , 2003, Genome research.

[20]  I. Bièche,et al.  Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[21]  T. Shibahara,et al.  Over-expression of DNA methyltransferases and CDKN2A gene methylation status in squamous cell carcinoma of the oral cavity. , 2003, International journal of oncology.

[22]  K. Maruyama,et al.  The human DNA methyltransferases DNMT3A and DNMT3B have two types of promoters with different CpG contents. , 2002, Biochimica et biophysica acta.

[23]  Hongbing Shen,et al.  A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer. , 2002, Cancer research.

[24]  S. Hirohashi,et al.  Overexpression of a splice variant of DNA methyltransferase 3b, DNMT3b4, associated with DNA hypomethylation on pericentromeric satellite regions during human hepatocarcinogenesis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Yu-Sun Chang,et al.  The Epstein–Barr virus oncogene product, latent membrane protein 1, induces the downregulation of E-cadherin gene expression via activation of DNA methyltransferases , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[26]  J. Kwong,et al.  High frequency of promoter hypermethylation of RASSF1A in nasopharyngeal carcinoma. , 2001, Cancer research.

[27]  T. Bestor,et al.  The DNA methyltransferases of mammals. , 2000, Human molecular genetics.

[28]  K. Hung,et al.  A new MALDI-TOF based mini-sequencing assay for genotyping of SNPS. , 2000, Nucleic acids research.

[29]  R. Momparler,et al.  DNA methylation and cancer , 2000, Journal of cellular physiology.

[30]  M. Hsu,et al.  Nasopharyngeal carcinoma in Taiwan clinical manifestations and results of therapy , 1983, Cancer.

[31]  P. Johnson,et al.  Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.